Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Nova 7028 - Liq 6 X Liquid is a Health Canada–registered human drug (DIN 02121328) held by Nova Homeopathic Therapeutics Inc., containing Belladonna. Health Canada lists its status as Cancelled Post Market (status date 16 Oct 2007). Nexara Health has matched 21 registrations of Belladonna across 2 other regulated markets, 3 of them in the same strength and dosage form.

Health Canada registration

DIN02121328
Brand nameNova 7028 - Liq
Active ingredientBelladonna
Strength6 X
Dosage formLiquid
RouteOral
CompanyNova Homeopathic Therapeutics Inc.
StatusCancelled Post Market — 16 Oct 2007
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Belladonna registered in other markets

21 registrations of the same molecule in 2 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesBelladonnaEnergique, Inc.LiquidlistedFDA NDC
United StatesBelladonnaRxhomeo Private Limited d.b.a. Rxhomeo, IncLiquidlistedFDA NDC
United StatesBelladonna 7106Professional Complementary Health FormulasLiquidlistedFDA NDC
NetherlandsBelladonnaBOIRON (Messimy)4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LMUitsluitend apotheek of drogistEU national register
NetherlandsBelladonnaBOIRON (Messimy)4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LMGlobuliUitsluitend apotheek of drogistEU national register
United StatesBelladonnaHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesBelladonnaHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesBelladonnaHistorical RemediesPelletlistedFDA NDC
United StatesBelladonnaHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesBelladonnaHahnemann Laboratories, INC.PelletlistedFDA NDC

See every manufacturer of Belladonna worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Nova 7028 - Liq (DIN 02121328) marketed in Canada?

No. Health Canada lists DIN 02121328 as Cancelled Post Market as of 16 Oct 2007.

Who holds the Canadian licence for this product?

Nova Homeopathic Therapeutics Inc. is the company of record in the Health Canada Drug Product Database.

Is Belladonna registered outside Canada?

Yes — Nexara Health has matched 21 registrations in 2 other markets, including 3 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02121328, status date 2007-10-16; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02121328, status date 2007-10-16; national medicine registries: EU national register, FDA NDC.

Health Canada Drug Product Database (DPD), DIN 02121328, status date 2007-10-16; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.